Giménez, Estela <br/><br/>
Monitoring of trough plasma ganciclovir levels and peripheral blood cytomegalovirus (CMV)-specific CD8+ T cells to predict CMV DNAemia clearance in preemptively treated allogeneic stem cell transplant recipients.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Sep 2014 
 - 5602-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.02953-14  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anemia, Aplastic--surgery<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cytomegalovirus--drug effects<br/>Cytomegalovirus Infections--drug therapy<br/>DNA, Viral--blood<br/>Female<br/>Ganciclovir--analogs & derivatives<br/>Humans<br/>Interferon-gamma--blood<br/>Leukemia, Myeloid, Acute--surgery<br/>Lymphoma, Non-Hodgkin--surgery<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--surgery<br/>Phosphoproteins--blood<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--surgery<br/>Stem Cell Transplantation<br/>Transplant Recipients<br/>Valganciclovir<br/>Viral Matrix Proteins--blood